Canopy Growth (CGC) Assets Average (2018 - 2025)
Canopy Growth's (CGC) quarterly Assets Average came in at $785.3 million in Q4 2025, up 14.94% year-on-year from $683.2 million in Q4 2024, and up 9.81% quarter-over-quarter from $715.1 million in Q3 2025.
Canopy Growth (CGC) Assets Average (2018 - 2025) Analysis & Trends
Canopy Growth has disclosed Assets Average across 8 years of filings, most recently posting $785.3 million for Q4 2025.
- Assets Average for Q4 2025 came in at $785.3 million, up 14.94% year-over-year; the trailing twelve-month figure through Dec 2025 was $785.3 million (up 14.94% YoY), and the FY2025 annual result was $802.3 million, down 42.07% from the prior year.
- Assets Average came in at $785.3 million for Q4 2025 at Canopy Growth, up from $715.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $5.5 billion in Q2 2021 to a low of $551.3 million in Q1 2025.
- The 5-year median for Assets Average is $1.6 billion (2023), against an average of $2.3 billion.
- Across the five-year window, Assets Average plunged 57.9% in 2023 and advanced 14.94% in 2025, its largest moves.
- Canopy Growth's Assets Average stood at $5.1 billion in 2021, then plunged by 53.64% to $2.4 billion in 2022, then tumbled by 52.38% to $1.1 billion in 2023, then tumbled by 39.09% to $683.2 million in 2024, then climbed by 14.94% to $785.3 million in 2025.
- The last three Assets Average figures came in at $785.3 million (Q4 2025), $715.1 million (Q3 2025), and $646.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.29 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 2.21 Bn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | 785.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 785.31 Mn |
| Sep 30, 2025 | 715.15 Mn |
| Jun 30, 2025 | 646.24 Mn |
| Mar 31, 2025 | 551.30 Mn |
| Dec 31, 2024 | 683.21 Mn |
| Sep 30, 2024 | 921.90 Mn |
| Jun 30, 2024 | 952.70 Mn |
| Mar 31, 2024 | 981.89 Mn |
| Dec 31, 2023 | 1.12 Bn |
| Sep 30, 2023 | 1.44 Bn |
| Jun 30, 2023 | 1.72 Bn |
| Mar 31, 2023 | 1.99 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.65 Bn |
| Jun 30, 2022 | 3.59 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 5.08 Bn |
| Sep 30, 2021 | 5.41 Bn |
| Jun 30, 2021 | 5.53 Bn |
| Mar 31, 2021 | 5.12 Bn |